🔗 Share this article

An underground economy for unlicensed weight-loss medications is propelled by social media fitness personalities and sellers on messaging platforms, based on new investigations.

Experimental Treatment Gaining Popularity Online

The experimental drug, which remains in clinical trials, is being promoted by online personalities for its alleged fat-burning properties. Viewers are encouraged to message these accounts directly for supplier links, while also receiving discount codes.

Thriving Commerce on Social Networks

Additionally, a robust trade exists on Telegram, where communities with thousands of members share comparison images, injection guides and assertions of next-day British shipping. Vendors market the substance there before redirecting buyers to other platforms for transactions.

Understanding The Experimental Drug

This medication is an experimental injection created by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could help patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Healthcare Professionals Voice Concerns

However, doctors and pharmacists have cautions that the sale of what is still an unlicensed drug in the UK is worrisome and could result in users injecting products of unknown origin.

Some professionals stated the popularity for retatrutide could be linked to the increasing cost of approved slimming products such as Mounjaro.

Regulatory Status and Implementation

Selling the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unlicensed drug that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Several influencers attempt to circumvent the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still violate pharmaceutical, marketing, and consumer regulations, risking fines, prosecution or imprisonment.

Platform Reaction and Material Removal

According to the social media company, the platform has removed problematic material and prohibited associated hashtags and search suggestions. The company said it was committed to keeping the service safe and allocating resources in strengthening enforcement strategies.

Digital Marketplace Operations

Investigations also found groups with up to nine thousand members selling the experimental drug using Telegram's integrated search feature, which operates like a public directory. Typing “retatrutide” immediately brings up groups with numerous of users, filled with images of weight loss, glowing testimonials and step-by-step guides for mixing or injecting at home.

Within moments of joining one group, a vendor shared WhatsApp details, where the majority of purchases occur. The seller sent an instruction manual and promised delivery within 48 hours. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one asked about body mass, medical conditions or past usage.

Item Details and Costs

Within these groups, messages show black plastic parcels with postal service labels, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at residence with purified liquid, or pre-filled pens usually priced at 160 pounds for 20mg. When questioned how long a pen should last, sellers give conflicting answers varying between a few weeks to “depends on your body”.

Service Moderation and Security Actions

A representative for the messaging service said it actively moderated harmful content on its platform including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are administering materials they cannot confirm. Even if the research behind retatrutide is sound, these digital products may not contain what they claim,” stated Jason Murphy, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to current price rises for approved slimming medications such as Mounjaro. “With prices rising, individuals are using online platforms. But counterfeit treatments are highly dangerous. You cannot know what’s inside or whether the environment they were made in was sterile,” she explained.

Her staff has already seen individuals harmed by personal administration from unconfirmed sources. “We understand the frustration, but buying from Telegram or communication platforms is gambling with your well-being,” stated Wyllie. “These materials could be impure or improperly measured.”

Producer Statement

A representative from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been reviewed or approved by any government authority globally. “Therefore at this time no one can sell [it] for personal consumption,” they said, noting that any item “falsely representing itself as a company investigational substance not yet authorized … may expose patients to potentially serious health risks”.